The effects of statin use on inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials

[Display omitted] Current evidence suggests that statin use decreases the incidence of cardiovascular diseases (CVD) through reducing LDL cholesterol and decreasing inflammation. Metabolic syndrome (MetS) is usually associated with increased inflammatory markers and increased risk of CVD. We conduct...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pharmacological research 2019-03, Vol.141, p.85-103
Hauptverfasser:	Tabrizi, Reza, Tamtaji, Omid Reza, Mirhosseini, Naghmeh, Lankarani, Kamran B., Akbari, Maryam, Dadgostar, Ehsan, Borhani-Haghighi, Afshin, Peymani, Payam, Ahmadizar, Fariba, Asemi, Zatollah
Format:	Artikel
Sprache:	eng
Schlagworte:	Inflammatory markers Meta-analysis Metabolic syndrome Randomized control trial Statin use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!